Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00136916

Public ClinicalTrials.gov record NCT00136916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 3:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Exubera® (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 2 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial

Study identification

NCT ID
NCT00136916
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
635 participants

Conditions and interventions

Interventions

  • Inhaled Insulin Drug
  • Subcutaneous insulin Drug

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Feb 17, 2010

2002 – 2008

United States locations

U.S. sites
69
U.S. states
26
U.S. cities
60
Facility City State ZIP Site status
Pfizer Investigational Site Phoenix Arizona 85016
Pfizer Investigational Site Tucson Arizona 85715
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site Greenbrae California 94904
Pfizer Investigational Site Los Angeles California 90073
Pfizer Investigational Site Sacramento California 95816
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site San Luis Obispo California 93401
Pfizer Investigational Site Tustin California 92780
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Denver Colorado 80209
Pfizer Investigational Site Hamden Connecticut 06518
Pfizer Investigational Site Madison Connecticut 06443
Pfizer Investigational Site New Britain Connecticut 06050
Pfizer Investigational Site Waterbury Connecticut 06708
Pfizer Investigational Site Chiefland Florida 32626
Pfizer Investigational Site Clearwater Florida 33761
Pfizer Investigational Site Fort Myers Florida 33901
Pfizer Investigational Site Hollywood Florida 33021
Pfizer Investigational Site Miami Florida 33156
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Palm Harbor Florida 34684
Pfizer Investigational Site Tallahassee Florida 32308
Pfizer Investigational Site West Palm Beach Florida 33401
Pfizer Investigational Site Honolulu Hawaii 96813
Pfizer Investigational Site Honolulu Hawaii 96814
Pfizer Investigational Site Chicago Illinois 60602
Pfizer Investigational Site Chicago Illinois 60607
Pfizer Investigational Site Chicago Illinois 60610
Pfizer Investigational Site Springfield Illinois 62704
Pfizer Investigational Site Wilmette Illinois 60091
Pfizer Investigational Site New Orleans Louisiana 70112
Pfizer Investigational Site Bethesda Maryland 20817
Pfizer Investigational Site Boston Massachusetts 02215
Pfizer Investigational Site Ann Arbor Michigan 48106
Pfizer Investigational Site Bloomfield Hills Michigan 48302
Pfizer Investigational Site Plymouth Michigan 48170
Pfizer Investigational Site Royal Oak Michigan 48073
Pfizer Investigational Site Southfield Michigan 48034
Pfizer Investigational Site Chesterfield Missouri 63017
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Butte Montana 59701
Pfizer Investigational Site Lincoln Nebraska 68521
Pfizer Investigational Site Henderson Nevada 89014
Pfizer Investigational Site Albuquerque New Mexico 87108
Pfizer Investigational Site Albuquerque New Mexico 87109
Pfizer Investigational Site Mineola New York 11501
Pfizer Investigational Site New Hyde Park New York 11042
Pfizer Investigational Site Rochester New York 14609
Pfizer Investigational Site Durham North Carolina 27713
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Mansfield Ohio 44903
Pfizer Investigational Site Tulsa Oklahoma 74104
Pfizer Investigational Site Warwick Rhode Island 02886
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Beaumont Texas 77706
Pfizer Investigational Site Corpus Christi Texas 78411
Pfizer Investigational Site Corpus Christi Texas 78412
Pfizer Investigational Site Dallas Texas 75230
Pfizer Investigational Site Dallas Texas 75231
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Houston Texas 77079
Pfizer Investigational Site Irving Texas 75061
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Burlington Vermont 05401
Pfizer Investigational Site Richmond Virginia 23225
Pfizer Investigational Site Renton Washington 98055
Pfizer Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00136916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2010 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00136916 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →